Dow Up 0.76% Nasdaq Up 0.69%

AVEO Pharmaceuticals, Inc. (AVEO)

-NasdaqGS
0.97 Down 0.05(4.90%) Oct 24, 3:59PM EDT
Prev Close:1.02
Open:1.02
Bid:0.90 x 10000
Ask:1.09 x 1000
1y Target Est:1.67
Beta:0.88
Next Earnings Date:N/A
Day's Range:0.92 - 1.02
52wk Range:0.85 - 2.32
Volume:191,673
Avg Vol (3m):355,255
Market Cap:50.21M
P/E (ttm):N/A
EPS (ttm):-1.27
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for AVEO

Comparison

Symbol% ChgMkt Cap
AVEODown 4.90%50.21M
AMGNUp 0.01%111.86B
PFEUp 1.78%184.58B
RHHBYDown 0.19%248.56B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2.97
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.92
Quarterly EPS Est (Sep-14) :-0.23
Mean Recommendation*:3.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AVEO Pharmaceuticals, Inc., doing business as AVEO Oncology, a biopharmaceutical company, is engaged in discovering, developing, and commercializing targeted cancer therapies using its Human Response Platform. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback